Interview with Michel Bouvier, Principal Investigator and Chief Executive Officer of Institute for Research in Immunology and Cancer (IRIC) on Canada’s Cancer Research Excellence.
Watch or read the full episode on our site.
Michel Bouvier is the CEO and one of the principal investigators at The Institute for Research in Immunology and Cancer (IRIC). He is also a professor of biochemistry and molecular medicine at Université de Montréal, where he also served as the Associate Vice-President in Research, Scientific Discovery, Creation, and Innovation. He holds the Canada Research Chair in Cell Signaling and Molecular Pharmacology.
Follow us for more interviews on Canada's future economy: